Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wastingin vivo

Vastus Lateralis Fiber Shift Is an Independent Predictor of Mortality in Chronic Obstructive Pulmonary Disease

(2014) Mehul S. Patel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Characteristics and determinants of endurance cycle ergometry and six-minute walk distance in patients with COPD

(2014) Vasileios Andrianopoulos et al.   BMC Pulmonary Medicine

Change in Growth Differentiation Factor 15 Concentrations over Time Independently Predicts Mortality in Community-Dwelling Elderly Individuals

(2013) K. M. Eggers et al.   CLINICAL CHEMISTRY

Sustained Elevation of Circulating Growth and Differentiation Factor-15 and a Dynamic Imbalance in Mediators of Muscle Homeostasis Are Associated With the Development of Acute Muscle Wasting Following Cardiac Surgery*

(2013) Susannah A.A. Bloch et al.   CRITICAL CARE MEDICINE

Lung function indices for predicting mortality in COPD

(2013) Afroditi K. Boutou et al.   EUROPEAN RESPIRATORY JOURNAL

Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (Copd); implications for stratified medicine?

(2013) Samantha A. Natanek et al.   MUSCLE & NERVE

CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD

(2013) Alejandro A. Díaz et al.   RESPIRATORY MEDICINE

Quadriceps wasting and physical inactivity in patients with COPD

(2012) Dinesh Shrikrishna et al.   EUROPEAN RESPIRATORY JOURNAL

Pathways associated with reduced quadriceps oxidative fibres and endurance in COPD

(2012) Samantha A. Natanek et al.   EUROPEAN RESPIRATORY JOURNAL

Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15

(2012) Vicky W. W. Tsai et al.   Journal of Cachexia Sarcopenia and Muscle

Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension

(2011) C. J. Rhodes et al.   HEART

Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD

(2011) Amy Lewis et al.   THORAX

Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality

(2010) Fredrik E. Wiklund et al.   AGING CELL

Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With Nephropathy

(2010) M. Lajer et al.   DIABETES CARE

Macrophage inhibitory cytokine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes: the Whitehall II study

(2010) Maren Carstensen et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Health-related quality of life in patients by COPD severity within primary care in Europe

(2010) P.W. Jones et al.   RESPIRATORY MEDICINE

Skeletal muscle dysfunction in COPD: clinical and laboratory observations

(2009) William D.-C. Man et al.   CLINICAL SCIENCE

Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss

(2009) Savita Wakchoure et al.   PROSTATE